Stockreport

Quince Therapeutics clears $16M EIB debt; shares surge 18% [Seeking Alpha]

Quince Therapeutics, Inc.  (QNCX) 
PDF CEO & CMO Dirk Thye said the company had settled its EIB debt to allow more flexibility to explore options like mergers, asset sales, or other deals to enhance sharehol [Read more]